Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
暂无分享,去创建一个
T. Costigan | S. Edelman | T. Blevins | P. Hollander | M. Prince | W. Huster | L. Ilag | M. Deeg | R. Ortmann | R. Konrad | J. Zielonka | R. Pollom